About IMPEDIMED INC
ImpediMed is a company that develops and provides FDA-cleared Bioimpedance Spectroscopy (BIS) technology for non-invasive measurement of fluid status and tissue composition in various patient populations. Their SOZO® Digital Health Platform is used in cancer survivorship, heart health management, and wellness applications.
Non-invasive measurement of fluid status and tissue composition using BIS technologyFDA-cleared digital health platform for real-time patient monitoringL-Dex® Analysis for early detection of lymphedemaBodyComp™ Analysis for tracking fluid volumes and tissue compositionHF-Dex™ Analysis for heart failure management
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $95K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to IMPEDIMED INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.